rs3732357

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_003889.4(NR1I2):​c.519+285G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.581 in 151,970 control chromosomes in the GnomAD database, including 27,865 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.58 ( 27865 hom., cov: 31)

Consequence

NR1I2
NM_003889.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.119

Publications

26 publications found
Variant links:
Genes affected
NR1I2 (HGNC:7968): (nuclear receptor subfamily 1 group I member 2) This gene product belongs to the nuclear receptor superfamily, members of which are transcription factors characterized by a ligand-binding domain and a DNA-binding domain. The encoded protein is a transcriptional regulator of the cytochrome P450 gene CYP3A4, binding to the response element of the CYP3A4 promoter as a heterodimer with the 9-cis retinoic acid receptor RXR. It is activated by a range of compounds that induce CYP3A4, including dexamethasone and rifampicin. Several alternatively spliced transcripts encoding different isoforms, some of which use non-AUG (CUG) translation initiation codon, have been described for this gene. Additional transcript variants exist, however, they have not been fully characterized. [provided by RefSeq, Jul 2008]
NR1I2 Gene-Disease associations (from GenCC):
  • pediatric lymphoma
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003889.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.694 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003889.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NR1I2
NM_003889.4
MANE Select
c.519+285G>A
intron
N/ANP_003880.3
NR1I2
NM_022002.3
c.636+285G>A
intron
N/ANP_071285.1O75469-7
NR1I2
NM_033013.3
c.519+285G>A
intron
N/ANP_148934.1O75469-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NR1I2
ENST00000393716.8
TSL:1 MANE Select
c.519+285G>A
intron
N/AENSP00000377319.3O75469-1
NR1I2
ENST00000337940.4
TSL:1
c.636+285G>A
intron
N/AENSP00000336528.4O75469-7
NR1I2
ENST00000466380.6
TSL:1
c.519+285G>A
intron
N/AENSP00000420297.2O75469-4

Frequencies

GnomAD3 genomes
AF:
0.582
AC:
88327
AN:
151852
Hom.:
27881
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.313
Gnomad AMI
AF:
0.781
Gnomad AMR
AF:
0.680
Gnomad ASJ
AF:
0.693
Gnomad EAS
AF:
0.642
Gnomad SAS
AF:
0.581
Gnomad FIN
AF:
0.642
Gnomad MID
AF:
0.636
Gnomad NFE
AF:
0.699
Gnomad OTH
AF:
0.602
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.581
AC:
88322
AN:
151970
Hom.:
27865
Cov.:
31
AF XY:
0.581
AC XY:
43172
AN XY:
74250
show subpopulations
African (AFR)
AF:
0.313
AC:
12951
AN:
41426
American (AMR)
AF:
0.680
AC:
10382
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.693
AC:
2403
AN:
3470
East Asian (EAS)
AF:
0.642
AC:
3314
AN:
5160
South Asian (SAS)
AF:
0.582
AC:
2801
AN:
4816
European-Finnish (FIN)
AF:
0.642
AC:
6786
AN:
10562
Middle Eastern (MID)
AF:
0.619
AC:
182
AN:
294
European-Non Finnish (NFE)
AF:
0.699
AC:
47521
AN:
67942
Other (OTH)
AF:
0.601
AC:
1270
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1673
3347
5020
6694
8367
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
730
1460
2190
2920
3650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.672
Hom.:
103598
Bravo
AF:
0.577
Asia WGS
AF:
0.594
AC:
2066
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
2.9
DANN
Benign
0.37
PhyloP100
-0.12
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs3732357;
hg19: chr3-119530858;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.